ÂÜÀòÂÒÂ×

Sara Gans is a Principal Scientist in Chemical Biology at Merck since December 2020, following a distinguished tenure at Novartis Institutes for BioMedical Research from July 2006 to December 2020, where roles included Principal Scientist I in both Exploratory Immuno-Oncology and Chemical Biology and Therapeutics, and Senior Scientist positions. Earlier experience includes a role as Research Technician in Medical Oncology at Dana-Farber Cancer Institute from June 2004 to July 2006, in William C Hahn's Lab. Sara Gans holds a Bachelor's Degree in Biochemistry from the University of New Hampshire, earned between 2000 and 2004.